Anne Morin-Welfringer
Paris, 75015, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Cutaneous Pediatric Vasculitis: A Clinico-Histopathological Overview of Common and Novel Entities.
Journal: Dermatopathology (Basel, Switzerland)
Published: February 04, 2026
Familial lupus associated with a P2RY8 variant: Navigating the boundary between monogenic disease and genetic susceptibility to lupus.
Journal: Journal of human immunity
Published: January 14, 2026
French national protocol for diagnosis and management of pemphigoid gestationis.
Journal: Annales de dermatologie et de venereologie
Published: November 05, 2025
European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.
European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 21, 2025
Dazukibart for the treatment of severe TIF1γ-positive juvenile dermatomyositis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 17, 2025
Dazukibart for the treatment of severe TIF1γ-positive juvenile dermatomyositis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 17, 2025
Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study.
Journal: The Lancet. Infectious diseases
Published: July 14, 2025
Ruxolitinib and Tocilizumab for Child Bronchiolitis Obliterans After Toxic Epidermal Necrolysis.
Journal: Pediatrics
Published: June 30, 2025
Risk of persistent hypogammaglobulinaemia in children with autoimmune bullous dermatoses treated with rituximab.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 12, 2025
IFN-α levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5+ autoantibodies.
Journal: Rheumatology (Oxford, England)
Published: June 03, 2025
Characteristics and Therapeutic Strategies for Diffuse Cutaneous Mastocytosis.
Journal: JAMA dermatology
Published: May 28, 2025
Last Updated: 09/26/2026